Treatment
Rituximab and Hyaluronidase Human clinical trials
We’re tracking 3 recruiting studies that include Rituximab and Hyaluronidase Human, each written for real people, not researchers, below.
Recruiting studies
- NCT06337318RecruitingPhase 3
Comparing two drugs for low-tumor burden follicular lymphoma
This trial compares a standard drug called rituximab to a newer medicine called mosunetuzumab for people with a slow-growing type of lymphoma that is not causing many symptoms. The goal is to see if mosunetuzumab works better and has fewer side effects.
Birmingham, AlabamaAges 18 years+ - NCT05886036RecruitingPhase 2
Comparing rituximab vs mosunetuzumab for NLPHL
This trial compares two immunotherapy drugs, rituximab and mosunetuzumab, to see which works better for people with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) who need treatment. It's for both newly diagnosed and previously treated patients.
Duarte, CaliforniaAges 18 years+ - NCT07042295RecruitingPhase 2
Amivantamab or Cetuximab for Skin Cancer in People with Weakened Immune Systems
This trial tests two drugs, amivantamab with hyaluronidase or cetuximab, in people with weakened immune systems who have advanced skin cancer (squamous cell carcinoma). The goal is to see if these treatments can help shrink or control the cancer.
Birmingham, AlabamaAges 18 years+
What Rituximab and Hyaluronidase Human is being studied for
Conditions with recruiting Rituximab and Hyaluronidase Human studies.
Common questions
- Are there clinical trials studying Rituximab and Hyaluronidase Human?
- Yes. Clin2 currently lists 3 recruiting studies that include Rituximab and Hyaluronidase Human, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Rituximab and Hyaluronidase Human trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Rituximab and Hyaluronidase Human an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Rituximab and Hyaluronidase Human or a specific trial is right for you.
Related treatments
- Rituximab or Rituximab biosimilar
- Rituximab
- Human Umbilical Cord Mesenchymal Stem Cells
- Human albumin
- Recombinant Human Growth Hormone
- Human Dopaminergic Progenitor Cells
- Human Urinary Kallidinogenase
- Recombinant Human Adenovirus Type 5
- Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1
- Recombinant human erythropoietin
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.